SAMSUNG PHARM. Co., LTD. (KRX:001360)
1,490.00
+6.00 (0.40%)
At close: May 13, 2025, 3:30 PM KST
SAMSUNG PHARM. Co., LTD. Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2018 | FY 2017 | FY 2016 | 2011 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | 2011 - 2015 |
Cash & Equivalents | - | - | 3,151 | 2,932 | 5,390 | Upgrade
|
Short-Term Investments | - | - | 1,200 | 1,200 | 2,966 | Upgrade
|
Trading Asset Securities | - | - | 29,064 | 22,525 | 4,053 | Upgrade
|
Cash & Short-Term Investments | - | - | 33,415 | 26,657 | 12,409 | Upgrade
|
Cash Growth | - | - | 25.35% | 114.81% | -68.57% | Upgrade
|
Accounts Receivable | - | - | 16,700 | 15,433 | 15,540 | Upgrade
|
Other Receivables | - | - | 3,708 | 3,489 | 689.11 | Upgrade
|
Receivables | - | - | 32,712 | 23,077 | 19,045 | Upgrade
|
Inventory | - | - | 9,309 | 10,582 | 13,161 | Upgrade
|
Prepaid Expenses | - | - | 24.47 | 52.41 | 727.71 | Upgrade
|
Other Current Assets | - | - | 1,192 | 609.65 | 2,369 | Upgrade
|
Total Current Assets | - | - | 76,652 | 60,978 | 47,711 | Upgrade
|
Property, Plant & Equipment | - | - | 73,435 | 75,038 | 72,405 | Upgrade
|
Long-Term Investments | - | - | 955.16 | 491.56 | - | Upgrade
|
Goodwill | - | - | - | - | 1,437 | Upgrade
|
Other Intangible Assets | - | - | 383.23 | 213.99 | 1,044 | Upgrade
|
Long-Term Deferred Charges | - | - | 2,846 | 1,956 | 1,701 | Upgrade
|
Other Long-Term Assets | - | - | 6,375 | 15,516 | 13,985 | Upgrade
|
Total Assets | - | - | 160,647 | 154,194 | 138,285 | Upgrade
|
Accounts Payable | - | - | 4,692 | 6,211 | 4,285 | Upgrade
|
Accrued Expenses | - | - | 27.47 | 388.64 | 110.69 | Upgrade
|
Short-Term Debt | - | - | 13,563 | 39,503 | 18,700 | Upgrade
|
Current Portion of Long-Term Debt | - | - | 2,748 | 957.96 | 9,176 | Upgrade
|
Current Income Taxes Payable | - | - | 2.59 | - | - | Upgrade
|
Current Unearned Revenue | - | - | - | - | 7.11 | Upgrade
|
Other Current Liabilities | - | - | 3,660 | 5,118 | 4,229 | Upgrade
|
Total Current Liabilities | - | - | 24,693 | 52,178 | 36,508 | Upgrade
|
Long-Term Debt | - | - | 2,150 | 4,906 | 16,307 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | - | - | 67.31 | Upgrade
|
Other Long-Term Liabilities | - | - | 615.45 | 784.58 | 659.3 | Upgrade
|
Total Liabilities | - | - | 28,984 | 60,326 | 55,907 | Upgrade
|
Common Stock | - | - | 29,118 | 20,713 | 19,857 | Upgrade
|
Additional Paid-In Capital | - | - | 82,305 | 99,155 | 94,371 | Upgrade
|
Retained Earnings | - | - | -3,380 | -49,655 | -43,435 | Upgrade
|
Treasury Stock | - | - | -154.04 | -154.04 | -154.04 | Upgrade
|
Comprehensive Income & Other | - | - | 23,774 | 23,809 | 11,739 | Upgrade
|
Total Common Equity | - | - | 131,663 | 93,868 | 82,378 | Upgrade
|
Minority Interest | - | - | - | - | 0 | Upgrade
|
Shareholders' Equity | - | - | 131,663 | 93,868 | 82,378 | Upgrade
|
Total Liabilities & Equity | - | - | 160,647 | 154,194 | 138,285 | Upgrade
|
Total Debt | - | - | 18,460 | 45,367 | 44,184 | Upgrade
|
Net Cash (Debt) | - | - | 14,955 | -18,710 | -31,774 | Upgrade
|
Net Cash Per Share | - | - | 291.86 | -468.99 | -970.09 | Upgrade
|
Filing Date Shares Outstanding | - | 67.12 | 58.19 | 41.39 | 39.67 | Upgrade
|
Total Common Shares Outstanding | - | 67.12 | 58.19 | 41.39 | 39.67 | Upgrade
|
Working Capital | - | - | 51,959 | 8,800 | 11,204 | Upgrade
|
Book Value Per Share | - | - | 2262.51 | 2268.17 | 2076.48 | Upgrade
|
Tangible Book Value | - | - | 131,280 | 93,655 | 79,896 | Upgrade
|
Tangible Book Value Per Share | - | - | 2255.93 | 2263.00 | 2013.93 | Upgrade
|
Land | - | - | 29,533 | 29,533 | 17,446 | Upgrade
|
Buildings | - | - | 30,336 | 19,328 | 36,855 | Upgrade
|
Machinery | - | - | 19,962 | 8,814 | 15,775 | Upgrade
|
Construction In Progress | - | - | 18,005 | 17,364 | 19,814 | Upgrade
|
Updated Nov 14, 2019. Source: S&P Global Market Intelligence. Standard template. Financial Sources.